 FDA Information - November 20, 2008
|
The Food and Drug Administration (FDA) has proposed a "Drug Watch" Web page that would list drug safety concerns that are being evaluated by the agency. The drug industry's U.S. lobbying group said the information the FDA wants to publicize "is too vague and preliminary to be of any value in making informed treatment and prescribing decisions |
|
By month's end, federal health officials hope to decide whether women will be allowed to buy emergency contraception without a prescription. The debate centers around the option of selling the pills over-the-counter, or implementing an age check, similiar to the requirements for alcohol and cigarettes |
|
What was once thought to be necessary tools in the fight against an epidemic have now gone to waste. Hundreds of thousands of flu shots ordered from Europe last year amid fears of a nationwide shortage have now expired and may go to waste, potentially costing taxpayers millions of dollars, officials say Wednesday in an Associated Press report |
|
A new insomnia drug, Rozerem, has been approved by The Food and Drug Administration, becoming the first drug of its kind not to be classified as a controlled substance. Because of its non-addictive classification, reports WCVB-TV in Boston, Rozerem can be used for long-term use |
|
Perrigo Co. says it is voluntarily recalling four types of liquid pain, cough and cold drops packaged with syringes that could prove inaccurate when measuring doses for children. The company declares the recall will cost about $2 million |
|